Dialysis Corporation of America (DCAI) Reports In-Line Q2 EPS of $0.07
Dialysis Corporation of America (Nasdaq: DCAI) reports Q2 EPS of $0.07, in-line with the analyst estimate of $0.07. Revenue for the quarter was $24.7 million, versus the consensus of $24.78 million.
Related Categories
EarningsStocks Mentioned
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
